财务类退市
Search documents
万方城镇投资发展股份有限公司关于2025年年报审计进展说明暨风险提示的公告
Shang Hai Zheng Quan Bao· 2026-02-26 18:30
Core Viewpoint - The company is facing significant financial challenges, with projected negative profits for 2025, and risks of being delisted due to financial performance and ongoing investigations [2][3][6]. Financial Performance - The company forecasts 2025 revenue between 200 million and 250 million, with net profit expected to be negative, ranging from -55 million to -40 million [3][6]. - The anticipated net profit attributable to shareholders is projected to be between -50 million and -35 million, indicating a challenging financial outlook [3][6]. Audit Progress - As of February 26, 2026, the audit for the 2025 annual report is still ongoing, with no significant discrepancies found between the audit evidence and the previously disclosed performance forecast [5]. - The company received a qualified opinion from the auditor regarding the recoverability of investments, which poses a risk for the 2025 audit report [4][7]. Risk Warnings - The company has been under delisting risk warning since April 30, 2025, and its stock is now traded under the name "*ST万方" with a daily price fluctuation limit of 5% [6]. - The company is also under investigation by the China Securities Regulatory Commission for alleged information disclosure violations, which could lead to further regulatory actions [8].
*ST精伦连续9日跌停 资金恐慌出逃
Jing Ji Guan Cha Wang· 2026-02-11 02:19
Group 1 - The core point of the article highlights that *ST Jinglun (600355.SH) has faced a continuous decline in stock price, hitting the limit down for nine consecutive trading days, with trading volume plummeting from 52 million yuan to less than 5 million yuan [1] - As of February 6, the stock price closed at 1.45 yuan per share, with approximately 100 million yuan still waiting to be sold at the limit down price [1] - The company is at risk of delisting due to failing to meet the new "National Nine Articles" financial delisting criteria, with a projected revenue of only 86.22 million yuan for 2025, falling short of the 300 million yuan threshold [1] Group 2 - The company’s Secretary Office confirmed that the Shanghai Stock Exchange identified a single customer risk in its computing server business, leading to the exclusion of this revenue, making delisting inevitable [1]
上海威尔泰工业自动化股份有限公司关于公司股票可能被终止上市的第二次风险提示公告
Shang Hai Zheng Quan Bao· 2026-02-09 18:19
Core Viewpoint - Shanghai Weitai Industrial Automation Co., Ltd. is at risk of being delisted due to negative financial performance, specifically if the audited revenue for 2025 falls below 300 million yuan and if the total profit, net profit, or net profit after deducting non-recurring gains and losses is negative [2][3]. Group 1 - The company reported that for the fiscal year 2024, the total profit, net profit, and net profit attributable to the parent company after deducting non-recurring gains and losses are expected to be negative, leading to a risk warning for delisting [2]. - The company’s stock was subjected to a delisting risk warning on April 30, 2025, due to the aforementioned financial conditions [2]. - According to the Shenzhen Stock Exchange listing rules, if the company fails to meet the financial criteria in 2025, it may face termination of its stock listing [3]. Group 2 - This is the second risk warning announcement regarding the potential delisting of the company's stock, following the first announcement made on January 26, 2026 [4]. - The company emphasizes that all information should be verified through designated media outlets, including Shanghai Securities Journal and Securities Times [4].
股票退市后能再上市吗?退市与再上市条件全解析
Sou Hu Cai Jing· 2026-02-05 23:16
Core Viewpoint - The possibility of relisting after delisting is not absolute, as some companies may still have the chance to relist, but the criteria for relisting are stringent and depend entirely on the reasons for delisting [1][29]. Group 1: Types of Delisting - Delisting is categorized into voluntary delisting and involuntary delisting, with the core premise for relisting being the distinction of the delisting nature [3]. - Companies that voluntarily delist for strategic adjustments, such as privatization or mergers, typically do not have significant legal violations and their operational fundamentals remain stable [4][5]. - Involuntary delisting, often due to regulatory non-compliance, is the most common scenario, with relisting conditions varying based on the reason for delisting [7]. Group 2: Relisting Conditions - Regardless of whether the delisting is voluntary or involuntary (excluding major legal violations), there are unified basic conditions for relisting, although there are slight differences across market segments [8]. - After delisting, companies must transition to the National Equities Exchange and Quotations (NEEQ) for trading [9]. - For trading-related delisting, companies can apply for relisting after 3 months; for financial-related delisting, they must wait for one full accounting year; and for major legal violations (excluding fraudulent issuance), a waiting period of 5 complete accounting years is required [10]. Group 3: Financial and Governance Requirements - For the main board, companies must have a positive net profit in the most recent year and revenue of at least 300 million yuan, or positive net profits in the last two years totaling over 30 million yuan, with positive net assets and no unremedied losses [11]. - For the Sci-Tech Innovation Board and Growth Enterprise Market, companies must have revenue of at least 100 million yuan, positive net profits in the last two years totaling over 40 million yuan, or a market capitalization of at least 10 billion yuan with revenue of at least 1 billion yuan [11]. - Companies must also have a sound governance structure, no significant internal control deficiencies, and no major legal violations by directors, supervisors, or senior management in the last three years [13]. Group 4: Restrictions on Relisting - Major legal violations leading to delisting impose strict restrictions or outright bans on relisting, with fraudulent issuance resulting in a lifetime ban [16]. - Companies delisted for major information disclosure violations must wait 5 accounting years to apply for relisting and must fully rectify the violations and handle civil compensation appropriately [17]. - Companies that have not completed rectification before delisting or have unresolved major litigation will not have their applications accepted [19]. Group 5: Relisting Process - The relisting process involves several stages: completing rectification post-delisting, hiring a sponsor for verification, and preparing application materials [21]. - Applications must be submitted to the target listing exchange along with audit reports and internal control reports [22]. - The exchange will conduct a thorough review focusing on financial authenticity and ongoing operational capability, ensuring transparency throughout the process [23]. Group 6: Common Misconceptions - A common misconception is that all delisted stocks can relist; however, stocks delisted for fraudulent issuance are permanently barred from relisting [26]. - Another misconception is that meeting the conditions guarantees approval; the exchange will evaluate ongoing operational capability comprehensively, with financial compliance being just a baseline requirement [27]. - Additionally, the belief that trading delisted stocks on the NEEQ will always yield profits is misleading, as the probability of relisting is low and most delisted stocks have poor liquidity, posing greater risks than opportunities [28].
万方城镇投资发展股份有限公司关于股票交易严重异常波动的公告
Shang Hai Zheng Quan Bao· 2026-01-28 18:03
Core Viewpoint - The company, WanFang Urban Investment Development Co., Ltd., is facing significant financial challenges, including a risk of delisting due to expected poor performance in 2025, with projected revenue below 300 million RMB and potential negative net profits [2][11]. Group 1: Stock Trading Abnormalities - The company's stock experienced a cumulative price drop of 13.18% over three consecutive trading days from January 26 to January 28, 2026, indicating abnormal trading activity [3]. - The stock has shown severe abnormal trading fluctuations, with four instances of similar trading behavior within ten consecutive trading days [3]. Group 2: Company Financial Performance - The company anticipates a revenue of less than 300 million RMB for the fiscal year 2025, with net profit or total profit expected to be negative [11]. - The company received a qualified audit report for 2024, raising uncertainties regarding the recoverability of investments, which may affect the 2025 audit report [12]. Group 3: Regulatory and Compliance Issues - The company is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, with no conclusive findings reported as of the announcement date [13]. - The company received a tax notification requiring the payment of late fees amounting to 30.45 million RMB, which will impact the 2025 net profit [17][18].
逾2万股东踩雷,*ST奥维多重风险叠加锁定市值退市
Di Yi Cai Jing· 2026-01-20 13:53
Core Viewpoint - *ST Ovi is likely to become the first stock in A-shares to trigger "market value delisting" by 2026, as its market capitalization has fallen below 5 billion yuan for 13 consecutive trading days, with a stock price below 1 yuan for 4 consecutive days [1][2][5] Group 1: Stock Performance - On January 20, *ST Ovi's stock price closed at 0.85 yuan, with a market capitalization of 2.948 billion yuan [1][2] - The stock has experienced 23 trading halts since December 1, 2025, including two instances of 8 consecutive trading halts [2][3] - To avoid delisting, *ST Ovi's stock price needs to rise to at least 1.44 yuan, requiring a 69.41% increase from the current price [2][3] Group 2: Financial Performance - The company has reported losses for three consecutive years, with a net profit loss of 461.15 million yuan for the fiscal year 2024 [6][7] - As of the end of the third quarter of 2025, the company reported a revenue of 34.0025 million yuan and a net profit loss of 188 million yuan [6][7] - The company faces potential delisting due to financial indicators, including negative net assets or non-standard audit opinions [6][7] Group 3: Operational Challenges - The decline in performance is attributed to the suspension of operations in its metal products business, which accounted for 88.36% of total revenue in 2024 [7][8] - The company is facing significant operational risks due to funds being occupied by its major shareholder and related parties, amounting to approximately 208 million yuan as of the end of 2024 [8] - The inability to conduct metal product operations is expected to have a major impact on the company's financial performance [7][8] Group 4: Market Context - Other companies in the A-share market, such as *ST Changyao and *ST Lifang, are also experiencing stock prices below 1 yuan, indicating a broader trend [4][5] - *ST Changyao's market capitalization has been below 3 billion yuan for eight consecutive trading days, which also puts it at risk of delisting [5]
*ST万方:股票交易异常波动,存财务及违法退市风险
Xin Lang Cai Jing· 2026-01-20 08:57
Core Viewpoint - The company *ST WanFang announced that its stock experienced an abnormal fluctuation with a cumulative decline of 14.06% over three consecutive trading days on January 16, 19, and 20, 2026, indicating potential financial distress [1] Financial Performance - The company expects its revenue for the fiscal year 2025 to be below 300 million yuan, with total profits projected to be negative [1] - There is uncertainty regarding the resolution of issues related to the audit report for 2024, which may lead to financial delisting scenarios [1] Regulatory Issues - The company has been under investigation by the China Securities Regulatory Commission (CSRC) since July 2025, which raises concerns about potential administrative penalties [1] - If the company faces significant legal violations leading to mandatory delisting, its stock may be forcibly delisted [1]
触及财务类退市情形,*ST万方公司股票或被终止上市
Zhong Guo Zheng Quan Bao· 2026-01-14 00:47
Core Viewpoint - The company *ST WanFang announced a significant expected decline in its 2025 revenue and potential delisting due to financial issues, with a projected revenue of less than 300 million yuan and negative profit figures [1][5][6]. Financial Performance - The company expects its 2025 revenue to be below 300 million yuan, with either total profit or net profit, or net profit after excluding non-recurring gains and losses, being negative [5][6]. - For the first three quarters of 2025, *ST WanFang reported approximately 176 million yuan in revenue, a year-on-year increase of 60.43%, but a net loss of about 8.59 million yuan compared to a profit of 13.29 million yuan in the same period last year [9]. Audit and Compliance - The company received a qualified audit opinion from Zhongxing Caiguanghua Accounting Firm for its 2024 financial statements, indicating uncertainty regarding the recoverability of investments in Jilin WanFang Bai'ao Biotechnology Co., Ltd [6][8]. - If the company receives a qualified audit opinion for its 2025 financial statements, it may trigger delisting under the Shenzhen Stock Exchange's regulations [6][8]. Corporate Actions - On January 13, the company announced the termination of the disposal of its remaining 13.67% stake in Beijing Tianyuan Real Estate Development Co., Ltd, deciding to retain this equity [7].
触及财务类退市情形 公司股票或被终止上市
Zhong Guo Zheng Quan Bao· 2026-01-13 15:10
Core Viewpoint - *ST WanFang announced that it expects its operating revenue for 2025 to be below 300 million yuan, with either total profit, net profit, or net profit after deducting non-recurring gains and losses being negative, which may lead to the termination of its stock listing due to financial delisting criteria [2][5]. Financial Performance - As of January 13, the company's stock price closed at 4.81 yuan per share, with a decline of 4.94% [2]. - For the first three quarters of 2025, *ST WanFang reported an operating revenue of approximately 176 million yuan, a year-on-year increase of 60.43%. However, it recorded a net loss attributable to shareholders of approximately -8.59 million yuan, compared to a profit of 13.29 million yuan in the same period last year [8]. Audit and Compliance - The company received a qualified audit opinion from Zhongxing Caiguanghua Accounting Firm for its 2024 financial statements, indicating uncertainty regarding the recoverability of investments in Jilin WanFang Bai'ao Biotechnology Co., Ltd. This uncertainty has not been resolved as of the announcement date, posing a risk of receiving a qualified audit opinion for the 2025 financial report [6][5]. - If the company receives a qualified audit opinion for 2025, it may trigger delisting risks under the Shenzhen Stock Exchange's regulations [6]. Corporate Actions - On January 13, *ST WanFang's board of directors approved the termination of the disposal of its remaining 13.67% stake in Beijing Tianyuan Real Estate Development Co., Ltd. The company will continue to hold this stake [7].
触及财务类退市情形,公司股票或被终止上市
Zhong Guo Zheng Quan Bao· 2026-01-13 15:05
Core Viewpoint - *ST WanFang (000638) announced that it expects its operating revenue for 2025 to be below 300 million yuan, with either total profit, net profit, or net profit after deducting non-recurring gains and losses being negative, which may lead to the termination of its stock listing due to financial delisting criteria [1][6][3]. Financial Performance - As of January 13, the company's stock price closed at 4.81 yuan per share, with a decline of 4.94% [2]. - For the first three quarters of 2025, *ST WanFang reported an operating revenue of approximately 176 million yuan, representing a year-on-year increase of 60.43%. However, it recorded a net loss attributable to shareholders of approximately -8.59 million yuan, compared to a profit of 13.29 million yuan in the same period last year [10]. Audit and Compliance - The company received a qualified audit opinion from Zhongxing Caiguanghua Accounting Firm for its 2024 financial statements, indicating significant uncertainty regarding the recoverability of investments in Jilin WanFang Bai'ao Biotechnology Co., Ltd. This uncertainty has not been resolved as of the announcement date, posing a risk of receiving a qualified audit opinion for the 2025 financial report [7][6]. - If the company receives a qualified audit opinion for 2025, it may trigger delisting risks under the Shenzhen Stock Exchange's regulations [7]. Corporate Actions - On January 13, *ST WanFang announced the termination of the disposal of its remaining 13.67% stake in Beijing Tianyuan Real Estate Development Co., Ltd. The company will continue to hold this stake [8][9].